المؤلفون: Morgan H; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia., Ndjeka N; National Department of Health, Tuberculosis Control and Management Cluster, Pretoria, South Africa., Hasan T; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia., Gegia M; Global Tuberculosis Program, World Health Organisation, Geneva, Switzerland., Mirzayev F; Global Tuberculosis Program, World Health Organisation, Geneva, Switzerland., Nguyen LN; Global Tuberculosis Program, World Health Organisation, Geneva, Switzerland., Schumacher S; Global Tuberculosis Program, World Health Organisation, Geneva, Switzerland., Schlub TE; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia., Naidoo K; Nelson R Mandela School of Medicine, University of KwaZulu Natal, Durban, South Africa., Fox GJ; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.

المصدر: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Jun 14; Vol. 78 (6), pp. 1698-1706.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Linezolid*/administration & dosage , Linezolid*/therapeutic use , Ethionamide*/therapeutic use , Ethionamide*/administration & dosage , Tuberculosis, Multidrug-Resistant*/drug therapy , Rifampin*/therapeutic use , Rifampin*/administration & dosage , Antitubercular Agents*/administration & dosage , Antitubercular Agents*/therapeutic use, Humans ; Retrospective Studies ; South Africa ; Male ; Female ; Adult ; Treatment Outcome ; Middle Aged ; Administration, Oral ; Young Adult ; Mycobacterium tuberculosis/drug effects

المؤلفون: Wang D; Department of Hospital Pharmacy, Graduate School of Medicine, Osaka University, Suita, Osaka 5650871, Japan., Ikemura K; Department of Hospital Pharmacy, Graduate School of Medicine, Osaka University, Suita, Osaka 5650871, Japan; Department of Pharmacy, Osaka University Hospital, Suita, Osaka 5650871, Japan. Electronic address: ikemurak@hp-drug.med.osaka-u.ac.jp., Hasegawa T; Department of Hospital Pharmacy, Graduate School of Medicine, Osaka University, Suita, Osaka 5650871, Japan., Yamane F; Department of Hospital Pharmacy, School of Pharmaceutical Sciences, Osaka University, Suita, Osaka 5650871, Japan., Okuda M; Department of Hospital Pharmacy, Graduate School of Medicine, Osaka University, Suita, Osaka 5650871, Japan; Department of Pharmacy, Osaka University Hospital, Suita, Osaka 5650871, Japan.

المصدر: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2024 Jun; Vol. 175, pp. 116801. Date of Electronic Publication: 2024 May 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1950-6007 (Electronic) Linking ISSN: 07533322 NLM ISO Abbreviation: Biomed Pharmacother Subsets: MEDLINE

مواضيع طبية MeSH: Linezolid*/adverse effects , Linezolid*/pharmacokinetics , Thrombocytopenia*/chemically induced , Thrombocytopenia*/metabolism, Humans ; HEK293 Cells ; Animals ; Male ; Female ; Middle Aged ; Retrospective Studies ; Aged ; Rats ; Proton Pump Inhibitors/adverse effects ; Proton Pump Inhibitors/pharmacology ; Lansoprazole/pharmacology ; Biological Transport ; Rats, Sprague-Dawley ; Risk Factors ; Adult ; Organic Anion Transporters, Sodium-Independent/metabolism

المؤلفون: Kengo A; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Nabeemeeah F; Perinatal HIV Research Unit (PHRU), University of the Witwatersrand, Johannesburg, South Africa., Denti P; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Sabet R; Perinatal HIV Research Unit (PHRU), University of the Witwatersrand, Johannesburg, South Africa., Okyere-Manu G; Perinatal HIV Research Unit (PHRU), University of the Witwatersrand, Johannesburg, South Africa., Abraham P; Perinatal HIV Research Unit (PHRU), University of the Witwatersrand, Johannesburg, South Africa., Weisner L; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Mosala MH; Perinatal HIV Research Unit (PHRU), University of the Witwatersrand, Johannesburg, South Africa., Tshabalala S; Bioengineering and Integrated Genomics Group, Council for Scientific and Industrial Research, Pretoria, South Africa., Scholefield J; Bioengineering and Integrated Genomics Group, Council for Scientific and Industrial Research, Pretoria, South Africa., Resendiz-Galvan JE; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Martinson NA; Perinatal HIV Research Unit (PHRU), University of the Witwatersrand, Johannesburg, South Africa.; Johns Hopkins University Center for Tuberculosis Research, Division of Infectious Diseases, School of Medicine, Baltimore, Maryland, USA., Variava E; Perinatal HIV Research Unit (PHRU), University of the Witwatersrand, Johannesburg, South Africa.; Department of Internal Medicine, University of the Witwatersrand, Klerksdorp/Tshepong Hospital Complex North-West Province, Klerksdorp-Tshepong, South Africa.

المصدر: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 May 02; Vol. 68 (5), pp. e0158323. Date of Electronic Publication: 2024 Apr 10.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE

مواضيع طبية MeSH: Clofazimine*/pharmacokinetics , Clofazimine*/therapeutic use , Drug Interactions* , Tuberculosis, Multidrug-Resistant*/drug therapy , Antitubercular Agents*/pharmacokinetics , Antitubercular Agents*/therapeutic use , Linezolid*/pharmacokinetics , Linezolid*/therapeutic use , Isoniazid*/pharmacokinetics , Isoniazid*/therapeutic use , Levofloxacin*/pharmacokinetics , Levofloxacin*/therapeutic use , Cycloserine*/pharmacokinetics , Cycloserine*/therapeutic use, Humans ; Adult ; Male ; Female ; Middle Aged ; South Africa ; Young Adult ; Drug Therapy, Combination

المؤلفون: Lyons MA; Department of Microbiology, Immunology and Pathology, Mycobacteria Research Laboratories, Colorado State University, Fort Collins, Colorado, USA., Obregon-Henao A; Department of Microbiology, Immunology and Pathology, Mycobacteria Research Laboratories, Colorado State University, Fort Collins, Colorado, USA., Ramey ME; Department of Microbiology, Immunology and Pathology, Mycobacteria Research Laboratories, Colorado State University, Fort Collins, Colorado, USA., Bauman AA; Department of Microbiology, Immunology and Pathology, Mycobacteria Research Laboratories, Colorado State University, Fort Collins, Colorado, USA., Pauly S; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Rossmassler K; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Reid J; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Karger B; Department of Microbiology, Immunology and Pathology, Mycobacteria Research Laboratories, Colorado State University, Fort Collins, Colorado, USA., Walter ND; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Consortium for Applied Microbial Metrics, Aurora, Colorado, USA.; Rocky Mountain Regional VA Medical Center, Aurora, Colorado, USA., Robertson GT; Department of Microbiology, Immunology and Pathology, Mycobacteria Research Laboratories, Colorado State University, Fort Collins, Colorado, USA.; Consortium for Applied Microbial Metrics, Aurora, Colorado, USA.

المصدر: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 May 02; Vol. 68 (5), pp. e0101023. Date of Electronic Publication: 2024 Mar 19.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE

مواضيع طبية MeSH: Antitubercular Agents*/pharmacology , Antitubercular Agents*/pharmacokinetics , Antitubercular Agents*/therapeutic use , Linezolid*/pharmacology , Linezolid*/pharmacokinetics , Diarylquinolines*/pharmacology , Diarylquinolines*/pharmacokinetics , Mice, Inbred BALB C* , Mycobacterium tuberculosis*/drug effects , Disease Models, Animal*, Animals ; Mice ; Female ; Nitroimidazoles/pharmacology ; Nitroimidazoles/pharmacokinetics ; Nitroimidazoles/therapeutic use ; Drug Therapy, Combination ; Lung/microbiology ; Lung/drug effects ; Tuberculosis/drug therapy ; Tuberculosis/microbiology ; Microbial Sensitivity Tests ; Tuberculosis, Pulmonary/drug therapy ; Tuberculosis, Pulmonary/microbiology

المؤلفون: Sadidi R; Department of Biology, College of Basic Sciences, Damghan Branch, Islamic Azad University, Damgan, Iran., Ajoudanifar H; Department of Biology, College of Basic Sciences, Damghan Branch, Islamic Azad University, Damgan, Iran., Ghasem Zadeh-Moghadam H; Department of Pathobiology and Laboratory Sciences, Faculty of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran., Azimian A; Department of Pathobiology and Laboratory Sciences, Faculty of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran.

المصدر: Iranian journal of medical sciences [Iran J Med Sci] 2024 May 01; Vol. 49 (5), pp. 332-338. Date of Electronic Publication: 2024 May 01 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Shiraz University of Medical Sciences Country of Publication: Iran NLM ID: 8104374 Publication Model: eCollection Cited Medium: Internet ISSN: 1735-3688 (Electronic) Linking ISSN: 02530716 NLM ISO Abbreviation: Iran J Med Sci Subsets: MEDLINE

مواضيع طبية MeSH: Linezolid*/pharmacology , Linezolid*/therapeutic use , Staphylococcus epidermidis*/drug effects , COVID-19*/epidemiology , Staphylococcal Infections*/drug therapy , Staphylococcal Infections*/epidemiology, Humans ; Iran/epidemiology ; Male ; Female ; Middle Aged ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Aged ; Coinfection/epidemiology ; Coinfection/drug therapy ; Coinfection/microbiology ; Drug Resistance, Bacterial/drug effects ; Adult ; SARS-CoV-2 ; Microbial Sensitivity Tests/methods

المؤلفون: Xu Q; Department of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.; Zhejiang Provincial Key Laboratory of Traditional Chinese Medicine for Clinical Evaluation and Translational Research, Hangzhou, China., Sang Y; Department of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China., Gao A; Department of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China., Li L; Department of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. lucille@zju.edu.cn.; Zhejiang Provincial Key Laboratory of Traditional Chinese Medicine for Clinical Evaluation and Translational Research, Hangzhou, China. lucille@zju.edu.cn.

المصدر: European journal of clinical pharmacology [Eur J Clin Pharmacol] 2024 Jun; Vol. 80 (6), pp. 785-795. Date of Electronic Publication: 2024 Feb 29.

نوع المنشور: Systematic Review; Journal Article; Review

بيانات الدورية: Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1041 (Electronic) Linking ISSN: 00316970 NLM ISO Abbreviation: Eur J Clin Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Drug Interactions* , Linezolid*/pharmacokinetics , Anti-Bacterial Agents*/pharmacokinetics , Anti-Bacterial Agents*/pharmacology, Humans

المؤلفون: Stojanova J; Department of Clinical Pharmacology and Toxicology, St. Vincent's Hospital, Sydney, NSW, Australia; School of Clinical Medicine, St Vincent's Healthcare Clinical Campus, Faculty of Medicine and Health, UNSW Sydney, NSW, Australia. Electronic address: jana.stojanova@svha.org.au., Brown JD; Clinical Microbiology and Infectious Diseases Department, St. Vincent's Hospital, Sydney, NSW, Australia., Reuter SE; UniSA Clinical & Health Sciences, University of South Australia, Adelaide, SA, Australia., Marriott DJE; Clinical Microbiology and Infectious Diseases Department, St. Vincent's Hospital, Sydney, NSW, Australia; School of Clinical Medicine, St Vincent's Healthcare Clinical Campus, Faculty of Medicine and Health, UNSW Sydney, NSW, Australia.

المصدر: International journal of antimicrobial agents [Int J Antimicrob Agents] 2024 Jun; Vol. 63 (6), pp. 107170. Date of Electronic Publication: 2024 Apr 09.

نوع المنشور: Case Reports; Letter

بيانات الدورية: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 9111860 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7913 (Electronic) Linking ISSN: 09248579 NLM ISO Abbreviation: Int J Antimicrob Agents Subsets: MEDLINE

مواضيع طبية MeSH: Linezolid*/pharmacokinetics , Linezolid*/therapeutic use , Critical Illness* , Anti-Bacterial Agents*/pharmacokinetics , Anti-Bacterial Agents*/therapeutic use, Humans ; Male ; Metabolic Clearance Rate ; Middle Aged ; Aged

المؤلفون: Şahin Y; Department of Neurosurgery, Marmara University School of Medicine, Istanbul, Turkey., Sayın E; Department of Microbiology, Marmara University School of Medicine, Istanbul, Turkey., Aslan Y; Department of Diving and Hyperbaric Medicine, TR Health Ministry Health Sciences University Istanbul Sultan Abdülhamit Han Training and Research Hospital, Istanbul, Turkey., Bayri Y; Department of Neurosurgery, Marmara University School of Medicine, Istanbul, Turkey. ybayri2000@yahoo.com.

المصدر: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery [Childs Nerv Syst] 2024 Jun; Vol. 40 (6), pp. 1765-1769. Date of Electronic Publication: 2024 Feb 06.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Springer International Country of Publication: Germany NLM ID: 8503227 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1433-0350 (Electronic) Linking ISSN: 02567040 NLM ISO Abbreviation: Childs Nerv Syst Subsets: MEDLINE

مواضيع طبية MeSH: Vancomycin* , Linezolid*/therapeutic use , Rats, Wistar* , Ventriculoperitoneal Shunt*/adverse effects , Hyperbaric Oxygenation*/methods , Disease Models, Animal* , Staphylococcal Infections*/drug therapy , Staphylococcus epidermidis*/drug effects , Anti-Bacterial Agents*/therapeutic use, Animals ; Rats ; Male ; Acetamides/therapeutic use ; Oxazolidinones/therapeutic use

المؤلفون: Liu C; Department of Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, No.1 Jianshe East Road, Erqi District, Zhengzhou, Henan Province, 450052, China.; Key Clinical Laboratory of Henan Province, Zhengzhou, China., Yu J; Department of Clinical Laboratory, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China., Chen C; Department of Clinical Laboratory, The Sixth People's Hospital of Zhengzhou City, Zhengzhou, China., Li X; Department of Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, No.1 Jianshe East Road, Erqi District, Zhengzhou, Henan Province, 450052, China.; Key Clinical Laboratory of Henan Province, Zhengzhou, China., Ye Y; Department of Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, No.1 Jianshe East Road, Erqi District, Zhengzhou, Henan Province, 450052, China.; Key Clinical Laboratory of Henan Province, Zhengzhou, China., Dong Y; Department of Clinical Laboratory, Yichuan People's Hospital, Zhengzhou, China., Ying X; Department of Clinical Laboratory, Luohe Sixth People's Hospital, Zhengzhou, China., Li H; Department of Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, No.1 Jianshe East Road, Erqi District, Zhengzhou, Henan Province, 450052, China.; Key Clinical Laboratory of Henan Province, Zhengzhou, China., Wang W; Department of Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, No.1 Jianshe East Road, Erqi District, Zhengzhou, Henan Province, 450052, China. 1259286625@qq.com.; Key Clinical Laboratory of Henan Province, Zhengzhou, China. 1259286625@qq.com.

المصدر: BMC infectious diseases [BMC Infect Dis] 2024 May 10; Vol. 24 (1), pp. 486. Date of Electronic Publication: 2024 May 10.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Linezolid*/pharmacology , Staphylococcal Infections*/microbiology , Staphylococcal Infections*/epidemiology , Anti-Bacterial Agents*/pharmacology , Tertiary Care Centers* , Microbial Sensitivity Tests*, Humans ; China/epidemiology ; Female ; Male ; Middle Aged ; Multilocus Sequence Typing ; Aged ; Whole Genome Sequencing ; Staphylococcus/drug effects ; Staphylococcus/genetics ; Staphylococcus/classification ; Staphylococcus/enzymology ; Coagulase/metabolism ; Coagulase/genetics ; RNA, Ribosomal, 23S/genetics ; Adult ; Methicillin Resistance/genetics ; Mutation ; Bacterial Proteins/genetics

المؤلفون: Wang Z; Department of Clinical Laboratory, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, No.1 Shuaifuyuan Wangfujing, Dongcheng, Beijing, 100730, P.R. China., Liu D; School of Engineering Medicine, Beihang University, Rd37, xueyuan, Haidian, Beijing, 100191, P.R. China.; Key Laboratory of Big Data-Based Precision Medicine, Beihang University, Ministry of Industry and Information Technology of the People's Republic of China, Beijing, China.; Key Laboratory of Biomechanics and Mechanobiology, Beihang University, Ministry of Education, Beijing, China., Zhang J; Department of Clinical Laboratory, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, No.1 Shuaifuyuan Wangfujing, Dongcheng, Beijing, 100730, P.R. China., Liu L; Department of Clinical Laboratory, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, No.1 Shuaifuyuan Wangfujing, Dongcheng, Beijing, 100730, P.R. China., Zhang Z; School of Engineering Medicine, Beihang University, Rd37, xueyuan, Haidian, Beijing, 100191, P.R. China.; Key Laboratory of Big Data-Based Precision Medicine, Beihang University, Ministry of Industry and Information Technology of the People's Republic of China, Beijing, China.; Key Laboratory of Biomechanics and Mechanobiology, Beihang University, Ministry of Education, Beijing, China., Liu C; Department of Clinical Laboratory, Beijing Huaxin Hospital, The First Hospital of Tsinghua University, Beijing, China., Hu S; State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China., Wu L; State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.; Microbial Resource and Big Data Center, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China., He Z; School of Engineering Medicine, Beihang University, Rd37, xueyuan, Haidian, Beijing, 100191, P.R. China. hezilong@buaa.edu.cn.; Key Laboratory of Big Data-Based Precision Medicine, Beihang University, Ministry of Industry and Information Technology of the People's Republic of China, Beijing, China. hezilong@buaa.edu.cn.; Key Laboratory of Biomechanics and Mechanobiology, Beihang University, Ministry of Education, Beijing, China. hezilong@buaa.edu.cn., Sun H; Department of Clinical Laboratory, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, No.1 Shuaifuyuan Wangfujing, Dongcheng, Beijing, 100730, P.R. China. sunhl2010@sina.com.

المصدر: Annals of clinical microbiology and antimicrobials [Ann Clin Microbiol Antimicrob] 2024 May 04; Vol. 23 (1), pp. 41. Date of Electronic Publication: 2024 May 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101152152 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-0711 (Electronic) Linking ISSN: 14760711 NLM ISO Abbreviation: Ann Clin Microbiol Antimicrob Subsets: MEDLINE

مواضيع طبية MeSH: Linezolid*/pharmacology , Gram-Positive Bacterial Infections*/microbiology , Gram-Positive Bacterial Infections*/epidemiology , Enterococcus faecium*/genetics , Enterococcus faecium*/drug effects , Microbial Sensitivity Tests* , Drug Resistance, Bacterial*/genetics , Whole Genome Sequencing* , Enterococcus faecalis*/drug effects , Enterococcus faecalis*/genetics , Anti-Bacterial Agents*/pharmacology, China/epidemiology ; Humans ; Retrospective Studies ; Enterococcus/drug effects ; Enterococcus/genetics ; Bacterial Proteins/genetics ; Genome, Bacterial ; Molecular Epidemiology ; Tertiary Care Centers ; Genomics